Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool
Alexandre Loureiro, Gabriela Silva
Antibiotics (2019) Vol. 8, Iss. 1, pp. 18-18
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
Małgorzata Łobocka, Krystyna Dąbrowska, Andrzej Górski
BioDrugs (2021) Vol. 35, Iss. 3, pp. 255-280
Open Access | Times Cited: 109
Impacts of Climate Change and Mitigation Strategies for Some Abiotic and Biotic Constraints Influencing Fruit Growth and Quality
Eunice Bacelar, Teresa Pinto, Rosário Anjos, et al.
Plants (2024) Vol. 13, Iss. 14, pp. 1942-1942
Open Access | Times Cited: 27
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
Ankit Kumar Dubey, Vijai Kumar Gupta, Małgorzata Kujawska, et al.
Journal of nanostructure in chemistry (2022) Vol. 12, Iss. 5, pp. 833-864
Open Access | Times Cited: 50
Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome
Arijit Nath, Rahul Bhattacharjee, Aditya Nandi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113122-113122
Open Access | Times Cited: 49
CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review
Emir Begagić, Hakija Bečulić, Nermin Đuzić, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 238-238
Open Access | Times Cited: 17
CRISPR/Cas genome editing in plants: mechanisms, applications, and overcoming bottlenecks
Delight Hwarari, Yasmina Radani, Yongchao Ke, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 13
Genome editing and its role in vaccine, diagnosis, and therapeutic advancement
Deepanker Bisht, Sagar Salave, Nimeet Desai, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131802-131802
Closed Access | Times Cited: 9
Engineering Useful Microbial Species for Pharmaceutical Applications
А.К. САДАНОВ, B.B. BAIMAKHANOVA, Saltanat Emilievna Orasymbet, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 599-599
Open Access | Times Cited: 1
Toward a next-generation diagnostic tool: A review on emerging isothermal nucleic acid amplification techniques for the detection of SARS-CoV-2 and other infectious viruses
Md Mamunul Islam, Dipak Koirala
Analytica Chimica Acta (2021) Vol. 1209, pp. 339338-339338
Open Access | Times Cited: 47
CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review
Nagaraj Bharathkumar, Sunil Abraham, Prabhakar Meera, et al.
Molecular Biotechnology (2021) Vol. 64, Iss. 4, pp. 355-372
Open Access | Times Cited: 42
MDR Pumps as Crossroads of Resistance: Antibiotics and Bacteriophages
Pavel A. Nazarov
Antibiotics (2022) Vol. 11, Iss. 6, pp. 734-734
Open Access | Times Cited: 32
Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals
Atif Khurshid Wani, Nahid Akhtar, Reena Singh, et al.
Veterinary Research Communications (2022) Vol. 47, Iss. 1, pp. 1-16
Closed Access | Times Cited: 32
Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System
Yared Abate Getahun, Destaw Asfaw Ali, Bihonegn Wodajnew Taye, et al.
Veterinary Medicine Research and Reports (2022) Vol. Volume 13, pp. 173-190
Open Access | Times Cited: 32
The Use of CRISPR-Cas9 Genetic Technology in Cardiovascular Disease: A Comprehensive Review of Current Progress and Future Prospective
Muhammad Asif, Wahab J Khan, Sadia Aslam, et al.
Cureus (2024)
Open Access | Times Cited: 8
Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects
Deepak Kumar Sahel, Gangadari Giriprasad, Reena Jatyan, et al.
RSC Advances (2024) Vol. 14, Iss. 44, pp. 32411-32435
Open Access | Times Cited: 6
CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases
Ansar Karimian, Negar Gorjizadeh, Forough Alemi, et al.
Life Sciences (2020) Vol. 259, pp. 118165-118165
Closed Access | Times Cited: 39
CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
Fikre Birhanu Balcha, Sultan Abda Neja
Animal Diseases (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 13
A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing
Nisha Choudhary, Dipty Tandi, Rakesh Kumar Verma, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 12
Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update
Nasim Bakhtiyari, Safar Farajnia, Samaneh Ghasemali, et al.
Infectious Disorders - Drug Targets (2024) Vol. 24, Iss. 6
Closed Access | Times Cited: 4
Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies
Prakhar Srivastava, Kwang-sun Kim
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2370-2370
Open Access | Times Cited: 17
Genomic insights into clostridia in bioenergy production: Comparison of metabolic capabilities and evolutionary relationships
Karan Kumar, Lepakshi Barbora, Vijayanand S. Moholkar
Biotechnology and Bioengineering (2023) Vol. 121, Iss. 4, pp. 1297-1312
Closed Access | Times Cited: 10
Synthetic biology and parasite genomics: engineering parasite-resistant human microbiomes for sustainable disease prevention
Esam S. Al‐Malki
Beni-Suef University Journal of Basic and Applied Sciences (2025) Vol. 14, Iss. 1
Open Access
Resolving the Trade‐Off Between Toxicity and Efficiency of CRISPR‐Cas9 System for Genome Editing Within Escherichia coli
Qian Guo, Qi Shen, Hao Qi, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 4
Closed Access
Application of Advanced CRISPR/Cas-9 and Other Genomic Tools in RNA-Based Therapeutics
Tehreem Fatima Awan, Muhammad Jadoon Khan
(2025), pp. 15-33
Closed Access
Synergistic Approaches to Foodborne Pathogen Control: A Narrative Review of Essential Oils and Bacteriophages
Rafail Fokas, Nikolaos Giormezis, Apostolos Vantarakis
Foods (2025) Vol. 14, Iss. 9, pp. 1508-1508
Open Access
Page 1 - Next Page

Scroll to top